Robot surgery: Globus shares dip on FDA delay

Shares of Globus Medical, the Audubon, Montgomery County-based spinal-treatment developer, fell as much as 9 percent in early trading Thursday after the company said its ExcelsiusGPS robotic-surgery platform would not gain the next level of Food and Drug Administration approval by June, as previously projected.

By midafternoon Globus shares had regained most of the loss and had topped $30. On May 4, Globus closed at $32.15, its highest price since going public (at $12) in 2012. The company employs 1,400. The stock closed at $30.33

"The FDA has not expressed any concern" over the technology "and is confident" it can be approved, Kyle Rose, an analyst at investment bank Canaccord Genuity Group, wrote in a report to clients, citing Globus management.

The delay followed FDA requests for "additional testing." Rose expects FDA seeks more data after testing systems from rival robotics developers Mazor and Zimmer Biomet. 

We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue
Help us moderate this thread by flagging comments that violate our guidelines

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Load comments
Continue Reading